Overall Sector and Industry Analysis
Datetime range analyzed (EST): 2025-11-18 from 14:00 to 19:00 (RTH into after-hours). Note: Only this intraday window was provided; I’m inferring short-term (1–3 day) momentum from late-day price/volume character rather than a full 30-day/10-day study.
- Health Care/Biotech dominated the tape and late-day flows:
- Large-cap pharma/biotech stayed firm to slightly bid: REGN (722.8→725.9 with strong 15:30 ramp), LLY (steady >$1,027 in AH), ARGX (tight but constructive).
- Mid/small-cap biotech showed momentum pivots and breakouts on expanding volume: SRRK (persistent higher highs into 39.99 test), OLMA (AH surge 18.1→19.4, likely catalyst-driven), ATEX (volume spike and breakout attempt), CNTA/KALV (heavy rotations but mixed closes).
- Consumer Discretionary was mixed:
- AZO churned and faded slightly late (3,835→3,823), while ONON held steady in AH around 42.75—no momentum edge without a fresh catalyst.
- Resources/Materials neutral to soft:
- HYMC popped intraday then churned in AH; SGML illiquid/flat—no clear read-through for lithium/gold beta near-term.
- Volatility ETNs (UVXY, UVIX) faded then bounced late, signaling a modest intraday risk-on that tempered into the close; until VIX products trend, equity momentum setups in growth/biotech have better odds.
- Tech/ID/security microcaps (IDN) saw spikes but thin AH liquidity—trade selectively.
Noticeable patterns
– Late-day accumulation and AH follow-through in selective biotech (SRRK, OLMA, ATEX) is the cleanest theme for 1–3 day momentum longs.
– Large-cap healthcare bid (REGN) provides a “risk anchor” backdrop—dips getting bought.
– Breakout-and-hold patterns with expanding volume beat mean-reversion plays today; avoid illiquid drifts unless there’s a catalyst.
Ticker Performance Prediction (next 2–3 days)
Most likely to go up: SRRK, OLMA, ATEX, LGN, CORD, REGN
Strongest bullish signals: SRRK (near 40 breakout on volume), OLMA (AH surge suggests news/interest), ATEX (late day range expansion + volume)
Individual Stock Analysis
Method notes: Using the 30-min structure you provided, obvious intraday swing highs/lows and round-number “supply/demand” for daily levels. For ATR-derived targets, I proxy recent intraday true range.
1) SRRK
– Setup: Trend day into close with higher highs, testing 39.99; volume accelerated late—prime for 40+ continuation.
– Key support: 39.21; 39.14; 38.72
– Key resistance: 39.99/40.00; 40.50; 41.00
– 2–3 day price action (30-min): If 39.30–39.50 holds on early retest, expect a 40.00 break; momentum push to 40.50 then 40.90–41.00 if volume persists. Lose 39.20 and a backfill to 38.90–38.70 likely before buyers attempt another push.
– 1–3 day targets: T1 40.20; T2 40.80–41.00
– Entries:
– Pullback: 39.35–39.50 with strength returning (higher low on 30-min).
– Breakout: Through 40.00 with >1.2x recent bar volume.
– Stop-loss: 39.05 (beneath 39.14 pivot); swing stop 38.60 (below demand shelf).
–
2) OLMA
– Setup: AH surge 18.1→19.4 with repeated tests near 19.2–19.4; suggests catalyst/accumulation. Watching for an opening-drive continuation.
– Key support: 19.00; 18.70; 17.90–18.10 zone (AH swing low 17.88 nearby)
– Key resistance: 19.43; 19.80; 20.00/20.50
– 2–3 day price action (30-min): Hold 19.00 on the open → retest 19.40–19.45; a clean break targets 19.80 then 20.20–20.50. If 18.70 fails, expect 18.20–18.00 liquidity check before recovery attempts.
– 1–3 day targets: T1 19.80; T2 20.20; stretch 20.80 if news tailwind persists.
– Entries:
– Pullback: 19.00–19.15 with reversal candle.
– Breakout: 19.45–19.50 through AH high on rising volume.
– Stop-loss: 18.65 (beneath 18.70); conservative swing stop 17.85 (below AH wash).
–
3) ATEX
– Setup: Range expansion and close near highs (21.26→21.79; close 21.69) on volume. Clean breakout candidate if 21.80/21.90 clears.
– Key support: 21.35; 21.26; 21.00
– Key resistance: 21.79; 22.00; 22.25/22.50
– 2–3 day price action (30-min): Early dip-bid at 21.35–21.45 → rotate back to 21.80; breakout over 21.80 opens 21.95–22.20; sustained push can tag 22.40–22.50. Lose 21.26 and a move to 21.05–21.00 likely before basing.
– 1–3 day targets: T1 21.95; T2 22.20–22.40
– Entries:
– Pullback: 21.35–21.45 with higher-low confirmation.
– Breakout: 21.80–21.85 with strong tape.
– Stop-loss: 21.18 (beneath 21.26); swing stop 20.95.
–
4) LGN
– Setup: Firm grind higher with repeated tests of 45–45.5 and higher lows. Looks like a 45.5 break/hold setup.
– Key support: 44.59; 44.20; 43.85
– Key resistance: 45.48; 46.00; 46.50
– 2–3 day price action (30-min): Above 44.60–44.80 demand, expect another 45.50 test; breakout could open 45.80 then 46.20–46.50. A loss of 44.59 likely backfills 44.20 before buyers re-engage.
– 1–3 day targets: T1 45.80; T2 46.20; stretch 46.80.
– Entries:
– Pullback: 44.70–44.90 on slowing sell volume.
– Breakout: 45.50+ with confirmation.
– Stop-loss: 44.35 (beneath 44.59); swing stop 43.75.
–
5) CORD
– Setup: Fast push 51.0→53.2 and held >53 in AH—momentum continuation if 53.2 clears.
– Key support: 52.48; 52.00; 51.30
– Key resistance: 53.23; 54.00; 54.50
– 2–3 day price action (30-min): Hold 52.50–52.80 and reclaim 53.20 → 53.80 then 54.20–54.50. If 52.48 fails, expect 52.00 test; bullish if buyers defend that zone.
– 1–3 day targets: T1 53.80; T2 54.20–54.50
– Entries:
– Pullback: 52.50–52.80 with reversal.
– Breakout: Through 53.25 with >1.2x bar volume.
– Stop-loss: 52.20; conservative swing stop 51.20.
–
6) REGN
– Setup: Large-cap strength, late day ramp and tight AH—low-drama continuation candidate.
– Key support: 722.10; 720.00; 717.50
– Key resistance: 727.97; 730.00; 735.00
– 2–3 day price action (30-min): Early hold above 723–725 likely re-tests 728; break targets 730 then 733–735. Lose 720 and a drift to 717–718 probable before dip buyers step back in.
– 1–3 day targets: T1 729.5; T2 733–735
– Entries:
– Pullback: 723.5–725.0 with market breadth supportive.
– Breakout: >728.0 on expanding volume.
– Stop-loss: 721.8; swing stop 717.2.
–
Additional quick notes
– Watch SRRK 40.00 and OLMA 19.45 as “go/no-go” momentum triggers; if both confirm with rising volume and broad tape risk-on, continuation odds improve across smaller-cap biotech peers (ATEX, CNTA, KALV).
– Volatility products (UVXY/UVIX) are not ideal for multi-day swings unless volatility regime shifts; treat any long equity momentum with respect to a sudden vol spike.
Risk management
– Size smaller on thinner names and into AH gaps; liquidity can disappear quickly.
– If market breadth or volatility flips risk-off (UVXY/UVIX trending up), tighten stops and favor taking profits at T1s.